GRACEcast Lung Cancer Video podcast

Artwork

Science Grace Cancergrace Lung Cancer Nsclc Chemotherapy Chemo Radiation Non Small Cell cancerGRACE - H. Jack West, MD Health and Well-Being Video Podcasting Education Medicine cancerGRACE - H. Jack West

Player FM - Internet Radio Done Right

22 subscribers

Health and Well-Being Videos

Dodano nine lat temu

Treść dostarczona przez cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

<

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/action-academy-replace-the-job-you-hate-with-a-life-you-love">Action Academy | Replace The Job You Hate With A Life You Love</a></span>

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/action-academy-replace-the-job-you-hate-with-a-life-you-love">Action Academy | Replace The Job You Hate With A Life You Love</a></span> podcast artwork

<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/action-academy-replace-the-job-you-hate-with-a-life-you-love">Action Academy | Replace The Job You Hate With A Life You Love</a></span> podcast artwork

1
Action Academy | Replace The Job You Hate With A Life You Love

Usuń subskrypcję

1 day temu1d ago

Usuń subskrypcję

Codziennie

Ready to replace your 6-figure salary with real freedom? This is the podcast for high earners who feel stuck in jobs they’ve outgrown. If you’re asking, “How do I actually replace $10K–$20K/month so I can quit and never look back?” — welcome home. At Action Academy, we teach you how to buy small businesses and commercial real estate to create cash flow that actually replaces your job. Monday through Friday, you’ll learn from 7–9 figure entrepreneurs, real estate moguls, and acquisition pros who’ve done it — and show you how to do it too. Hosted by Brian Luebben (@brianluebben), who quit his 6-figure sales role in 2022 to build a global business while traveling the world. If you're a high-income earner ready to become a high-impact entrepreneur, this show is your playbook. Subscribe now and start your path to freedom — or keep pretending your job will get better someday....

GRACEcast Lung Cancer Video

Udostępnij

Źródło serii•Feed

Treść dostarczona przez cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

… continue reading

301 odcinków

#Science #Grace #Cancergrace #Lung #Cancer #Nsclc #Chemotherapy #Chemo #Radiation #Non #Small #Cell #cancerGRACE - H. Jack West, MD #Health and Well-Being #Video #Podcasting Education #Medicine #cancerGRACE - H. Jack West

Artwork

GRACEcast Lung Cancer Video

22 subscribers

updated 11 lat temu

Udostępnij

Źródło serii•Feed

Treść dostarczona przez cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

… continue reading

301 odcinków

#Science #Grace #Cancergrace #Lung #Cancer #Nsclc #Chemotherapy #Chemo #Radiation #Non #Small #Cell #cancerGRACE - H. Jack West, MD #Health and Well-Being #Video #Podcasting Education #Medicine #cancerGRACE - H. Jack West

Wszystkie odcinki

×

Artwork

1
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 4:36

11 years temu4:36

4:36

Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.

Artwork

1
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 5:28

11 years temu5:28

5:28

The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.

Artwork

1
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 2:27

11 years temu2:27

2:27

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

Artwork

1
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 7:28

11 years temu7:28

7:28

The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.

Artwork

1
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope 7:22

11 years temu7:22

7:22

The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.

Artwork

1
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer 3:52

11 years temu3:52

3:52

"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).

Artwork

1
MET-Amplified Lung Cancer: A New Target for XALKORI? 7:18

11 years temu7:18

7:18

Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.

Artwork

1
CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer 4:10

11 years temu4:10

4:10

Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.

Artwork

1
FGFR and Its Role in Treating Squamous Cell Lung Cancer 2:21

11 years temu2:21

2:21

Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.

Artwork

1
AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer 11:36

11 years temu11:36

11:36

EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.

Artwork

1
What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer? 2:17

11 years temu2:17

2:17

"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.

Artwork

1
The Promise of Immunotherapy in Lung Cancer 1:21

11 years temu1:21

1:21

Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.

Artwork

1
Does Gilotrif Help EGFR Positive Lung Cancer Patients? 8:16

11 years temu8:16

8:16

An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer.

Artwork

1
Is Progression-Free Survival Meaningful? 3:25

11 years temu3:25

3:25

Progression-free survival is something that doctors measure to determine how well a patient responds to a particular treatment. But does it translate to increased overall survival?

Artwork

1
DDR2 Mutations in Squamous Cell Lung Cancer 1:07

11 years temu1:07

1:07

A genetic mutation and a leukemia drug may provide new hope for patients with squamous cell lung cancer patients.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Does Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients? 9:26

11 years temu9:26

9:26

Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGFR positive lung cancer patients increase progression-free survival. June 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
What is FGFR, and Could It Be a Valuable Target for Patients with Lung Cancer? 3:50

11 years temu3:50

3:50

Dr. Joel Neal of Stanford University Medical Center talks about FGFR - fibroblast growth factor receptor - and how it can impact non-small cell lung cancer growth.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
How Do We Make EGFR Inhibitors Work Better for Patients 3:15

11 years temu3:15

3:15

Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes what research indicates may be more successful treatments for EGFR lung cancer patients.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
TH 302: New Drug May Make Tumors Less Resistant to Treatment 1:26

11 years temu1:26

1:26

Dr. Jonathan Goldman discusses a drug currently being studied that may make lung cancer tumors more susceptible to treatment. February 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Should We Do Broad Sequencing of All Lung Tumors? 3:21

11 years temu3:21

3:21

How much detail is needed when determining how to treat lung cancer? Should patients be tested for all the mutations that may exist within their tumors? Dr. Jonathan Riess discusses this issue and how he makes decisions regarding his own patients.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
How Do the New ALK Inhibitor Drugs Compare to Xalkori (Crizotinib) for ALK+ Lung Cancer Patients? 4:58

11 years temu4:58

4:58

Xalkori (crizotinib) has had great success treating ALK positive lung cancer patients. The next generation of ALK inhibitors are also showing great promise. In this video, Dr. Leena Gandhi of Dana-Farber Cancer Institute talks about the research.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Why Are Non-Mutated EGFR Genes Called "Wild Type?" 1:21

11 years temu1:21

1:21

When it comes to EGFR and lung cancer, is a mutation good or bad? Dr. Joel Neal of Stanford University Medical Center explains why non-mutated genes are called "wild type." February 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Teaching the Immune System to Attack Lung Cancer Tumors 6:18

11 years temu6:18

6:18

Immune therapy, or immunotherapy, is one of the most exciting areas of lung cancer research. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center explains how immune therapy works and how it might impact the future of lung cancer treatment.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Advice for Lung Cancer Patients: Know Thy Cancer 1:32

11 years temu1:32

1:32

What should lung cancer patients know about their disease? Dr. Jonathan Riess argues that patients should understand what type of lung cancer they have and which, if any, mutations their lung tumors may have. He explains why in this video.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Is It Necessary for Early Stage Lung Cancer Patients to Get Molecular Testing for Their Tumors? 1:56

11 years temu1:56

1:56

If you were diagnosed with early stage lung cancer, should you receive molecular testing on your tumor in order to get targeted therapy? Dr. Joel Neal of Stanford University Medical Center discusses the reasons for and against it. February 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Treating EGFR Patients After Tarceva Stops Working 2:47

11 years temu2:47

2:47

Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center talks about the next generation EGFR inhibitors that may soon become available. February 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer? 1:43

11 years temu1:43

1:43

Dr. Joel Neal of Stanford University Medical Center discusses the SELECT clinical trial which studied early stage non-small cell lung cancer patients and whether or not Tarceva (erlotinib) would prevent disease recurrence. February 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
An Update on ECOG 1505: Will Avastin (Bevacizumab) Become Standard Treatment for Early Stage Lung Cancer Patients? 3:55

11 years temu3:55

3:55

Dr. Heather Wakelee of Stanford University Medical Center talks about how studies looking into Avastin (bevacizumab) for early stage lung cancer patients are progressing. February 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Targeted Treatment for Lung Cancer After Progression 4:48

11 years temu4:48

4:48

Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute discusses whether or not patients on targeted therapies, such as EGFR inhibitors, should stay on those therapies after their cancers begin to grow again. February 2014.

G

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Video podcast artwork

1
Can Vaccines Fight Lung Cancer? 2:25

11 years temu2:25

2:25

Dr. Charles Rudin of Memorial Sloan Kettering on the possibility of using vaccines to fight lung cancer. February 2014.

Zapraszamy w Player FM

Odtwarzacz FM skanuje sieć w poszukiwaniu wysokiej jakości podcastów, abyś mógł się nią cieszyć już teraz. To najlepsza aplikacja do podcastów, działająca na Androidzie, iPhonie i Internecie. Zarejestruj się, aby zsynchronizować subskrypcje na różnych urządzeniach.

Posłuchaj 500+ tematów

Skrócona instrukcja obsługi

Najlepsze podcasty

Black Hat Ultra

Mała Wielka Firma

Felieton Tomasza Olbratowskiego

Hammerzeit Podcast

YesWas | Podcast

Gość Krzysztofa Ziemca w RMF FM

Z pasją o mocnych stronach

Techniczny NXXI

Ameryka i ja - Lidia Krawczuk w RMF Classic

Prawdziwe Zbrodnie

Piąte: Nie zabijaj

Posłuchaj tego programu podczas zwiedzania